196 related articles for article (PubMed ID: 16797728)
1. Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
Vanderlocht J; Hendriks JJ; Venken K; Stinissen P; Hellings N
J Neuroimmunol; 2006 Aug; 177(1-2):189-200. PubMed ID: 16797728
[TBL] [Abstract][Full Text] [Related]
2. Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis.
Vanderlocht J; Hellings N; Hendriks JJ; Vandenabeele F; Moreels M; Buntinx M; Hoekstra D; Antel JP; Stinissen P
J Neurosci Res; 2006 Apr; 83(5):763-74. PubMed ID: 16477612
[TBL] [Abstract][Full Text] [Related]
3. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
[TBL] [Abstract][Full Text] [Related]
5. IFN-beta inhibits human Th17 cell differentiation.
Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
[TBL] [Abstract][Full Text] [Related]
6. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
7. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
[TBL] [Abstract][Full Text] [Related]
8. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
Hamamcioglu K; Reder AT
Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
[TBL] [Abstract][Full Text] [Related]
9. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
Reske D; Thomas AV; Petereit HF; Fink GR; Schroeter M
Neuroimmunomodulation; 2009; 16(6):385-91. PubMed ID: 19609087
[TBL] [Abstract][Full Text] [Related]
10. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
Bar-Or A; Fawaz L; Fan B; Darlington PJ; Rieger A; Ghorayeb C; Calabresi PA; Waubant E; Hauser SL; Zhang J; Smith CH
Ann Neurol; 2010 Apr; 67(4):452-61. PubMed ID: 20437580
[TBL] [Abstract][Full Text] [Related]
11. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
[TBL] [Abstract][Full Text] [Related]
12. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
Mei FJ; Osoegawa M; Ochi H; Minohara M; Nan S; Murai H; Ishizu T; Taniwaki T; Kira J
J Neurol Sci; 2006 Jul; 246(1-2):71-7. PubMed ID: 16581087
[TBL] [Abstract][Full Text] [Related]
13. Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.
Kieseier BC; Archelos JJ; Hartung HP
Arch Neurol; 2004 Jun; 61(6):929-32. PubMed ID: 15210533
[TBL] [Abstract][Full Text] [Related]
14. Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patientswith relapsing-remitting multiple sclerosis.
Gausling R; Trollmo C; Hafler DA
Clin Immunol; 2001 Jan; 98(1):11-7. PubMed ID: 11141321
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the immunogenicity of different interferon beta-1a formulations using ex vivo T-cell assays.
Jaber A; Baker M
J Pharm Biomed Anal; 2007 Mar; 43(4):1256-61. PubMed ID: 17118612
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients.
Desai F; Ramanathan M; Fink CS; Wilding GE; Weinstock-Guttman B; Awad AB
Int Immunopharmacol; 2009 Jan; 9(1):153-7. PubMed ID: 19022404
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line.
Bahbouhi B; Berthelot L; Pettré S; Michel L; Wiertlewski S; Weksler B; Romero IA; Miller F; Couraud PO; Brouard S; Laplaud DA; Soulillou JP
J Leukoc Biol; 2009 Nov; 86(5):1049-63. PubMed ID: 19696154
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.
Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Farhum F; Karni A
J Neurol Sci; 2010 Aug; 295(1-2):31-7. PubMed ID: 20541775
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.
Becher B; Giacomini PS; Pelletier D; McCrea E; Prat A; Antel JP
Ann Neurol; 1999 Feb; 45(2):247-50. PubMed ID: 9989628
[TBL] [Abstract][Full Text] [Related]
20. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
Miyazaki Y; Iwabuchi K; Kikuchi S; Fukazawa T; Niino M; Hirotani M; Sasaki H; Onoé K
Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
